Standards & complianceMulti-omicsIn-silicoDigital TwinConsent-boundYou own your dataGDPRDPDP
Platform · Digital biology layer

Simulate life before you test on it.

CytoMind is the interface to the Digital Twin. In the laboratory it simulates biology before a single experiment. In your hand it becomes the surface through which you see, understand and govern your own twin.

Simulating life. Enabling precision.
An important distinction

CytoMind operates the twin. The platform owns it.

There is one Digital Twin per person, held by the platform with one identity, one consent record and one contiguous audit trail. OmnigeniX writes molecular interpretation into it. TheraMind reads it at the point of care. CytoMind simulates against it and gives the individual a window onto it.

This matters more than it sounds. It is why a variant interpreted in a laboratory today is still readable by a clinician in ten years, and why a person can revoke consent once rather than product by product.

OmnigeniX writesMolecular interpretation, classified deterministically against a versioned evidence snapshot.
CytoMind creates and operatesBuilds the twin, runs trajectories against it, and surfaces it to the individual through the Personal Health Cloud.
TheraMind readsAt the point of care, at prescription, and after the dose.
MSI CORE™ orchestratesThe AI Agent Layer decomposes the task, routes to the right product, and composes the answer.
Why simulation

Biology is too complex, and too costly, to learn by trial and error.

Drug discovery still runs on experiments that take years and billions — with most candidates failing late, and data siloed across every omics layer.

~90%of drug candidates entering Phase I never reach approval
10–15 yrand $1–2bn to bring one new drug to clinical use
40–50%of clinical failures are due to lack of efficacy

Sources: Sun et al., Acta Pharmaceutica Sinica B (2022), on clinical development failure rates and their causes; consistent with the long-standing ~10% likelihood-of-approval figure reported across the literature.

Why in silico

Explore more, faster — safer, and for less.

Explore more, faster

Simulate years of biology in hours or days.

Safer and more ethical

Reduce reliance on animal models.

Lower cost, higher return

Fail in silico rather than in Phase II, where most attrition occurs.

Better predictions

More accurate outcomes across the pipeline.

Trusted by design

A twin is not a data lake.

Every twin carries its own provenance, consent status, model versions, uncertainty and audit history — and the person it describes can see all of it.

Provenance

Where every observation came from, by what method, at what version.

Consent status

What is shared, with whom, for what purpose, for how long.

Uncertainty

Calibrated intervals, and an explicit statement of what is not known.

Audit history

Every access recorded immutably, and visible to the person.

Get started

Simulate biology. Or understand your own.

Partner with the Virtual Cell Platform, or join the waitlist for the Personal Health Cloud — tell us which fits.